Abstract
We are particularly interested in testing the principles of cell proliferation and apoptosis in the microenvironment of human lung cancers with respect to the cell survival protein Akt1 and PTEN2. Akt is a cytosolic protein which promotes cell survival by phosphorylative inactivation of targets in apoptotic pathways. Akt has been found to play a role in the survival of experimental cancer cell lines in breast, prostate, ovary, lung and brain tissue. PTEN is a tumor suppressor gene whose protein product is expressed in inverse proportion to phosphorylated Akt in endometrial and breast cancer cell lines. No studies of the diagnostic significance of Akt and PTEN in human lung cancers have been reported.
Keywords: Akt, PTEN, cell survival, immunohistochemistry, lung cancer
References
- 1. American Cancer Society . Cancer Facts and Figures.
- 2. Hutchinson J., Jin J., Cardiff R.D., et al: Activation of Akt protein kinase B in mammary epithelium provides a critical cell survival signal required for tumor progression. Mol Cell Biol 21:2203–12., 2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Davies M.A., Koul D., Dhesi H., et al: Regulation of Akt/PKB activity, cellular growth, and apoptosis in prostate carcinoma cells by MMAC/PTEN. Cancer Res 59:2551–6.,1999. [PubMed] [Google Scholar]
- 4. Campbell R.A., Bhat‐Nakshatri P., Patel N.M., et al: Phosphatidylinositol 3‐kinase/AKT‐mediated activation of estrogen receptor alpha: a new model for antiestrogen resistance. J Biol Chem 276:9817–24.,2001. [DOI] [PubMed] [Google Scholar]
- 5. Moore S.M., Rintoul R.C., Walker T.R., et al: The presence of a constitutively active phosphoinositide 3‐kinase in small cell lung cancer cells mediates anchorage‐independent proliferation via a protein kinase B and p70s6k‐dependent pathway. Cancer Res 58:5239–47.,1998. [PubMed] [Google Scholar]
- 6. Nakashio A., Fujita N., Rokudai S., et al: Prevention of phosphatidylinositol 3′‐ kinase‐Akt survival signaling pathway during topotecan‐induced apoptosis. Cancer Res 60:5303–9.,2000. [PubMed] [Google Scholar]
- 7. Brognard J., Clark A.S., Ni Y., et al: Akt/protein kinase B is constitutively active in non‐small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation. Cancer Res 61:3986–97.,2001. [PubMed] [Google Scholar]
- 8. Cuello M., Ettenberg S.A., Clark A.S., et al: Down‐regulation of the erbB‐2 receptor by trastuzumab herceptin enhances tumor necrosis factor‐related apoptosis‐inducing ligand‐ mediated apoptosis in breast and ovarian cancer cell lines that overexpress erbB‐ 2. Cancer Res 61:4892–900.,2001. [PubMed] [Google Scholar]
- 9. Brunet A., Bonni A., Zigmond M.J., et al: Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96:857–68.,1999. [DOI] [PubMed] [Google Scholar]
- 10. Kanamori Y., Kigawa J., Itamochi H., et al: Correlation between loss of PTEN expression and Akt phosphorylation in endometrial carcinoma. Clin Cancer Res 7:892–5.,2001. [PubMed] [Google Scholar]
- 11. Weng L., Brown J., Eng C.: PTEN induces apoptosis and cell cycle arrest through phosphoinositol‐3‐ kinase/Akt‐dependent and ‐ independent pathways. Hum Mol Genet 10:237–42., 2001. [DOI] [PubMed] [Google Scholar]
- 12. Stambolic V., Suzuki A., de la Pompa J.L., et al: Negative regulation of PKB/Aktdependent cell survival by the tumor suppressor PTEN. Cell 95:29–39.,1998. [DOI] [PubMed] [Google Scholar]
- 13. Risinger J.I., Hayes K., Maxwell G.L., et al: PTEN mutation in endometrial cancers is associated with favorable clinical and pathologic characteristics. Clin Cancer Res 4:3005–10.,1998. [PubMed] [Google Scholar]
- 14. Hong T.M., Yang P.C., Peck K., et al: Profiling the downstream genes of tumor suppressor PTEN in lung cancer cells by complementary DNA microarray. Am J Respir Cell Mol Biol 23:355–63.,2000. [DOI] [PubMed] [Google Scholar]